...
首页> 外文期刊>Melanoma research >Compliance with guidelines in the surgical management of cutaneous melanoma across the USA
【24h】

Compliance with guidelines in the surgical management of cutaneous melanoma across the USA

机译:符合美国皮肤黑素瘤手术治疗指南

获取原文
获取原文并翻译 | 示例

摘要

The National Comprehensive Cancer Network has formulated guidelines for the management of cutaneous malignant melanoma with regard to resection margins (RMs) and regional staging. The aim of this study was to assess compliance with these recommendations in the general population of the USA. The Surveillance, Epidemiology and End-Results database was examined to identify 60 194 patients with malignant melanoma from 2004 to 2008. Multivariate logistic regression analysis was used to identify factors predictive of RM less than 1 cm and noncompliance with sentinel lymph node biopsy (SLNB). The median age of the population was 60 years and the mean Breslow thickness was 1.20±0.16 mm. The majority of patients had a RM of less than 1 cm (58%) and only 53% of eligible patients had undergone SLNB. Regional nodal dissection was performed in 69% of patients with a positive SLNB and in 78% with palpable lymphadenopathy. On multivariate analysis age more than 80 years [odds ratio (OR) 1.3, 95% confidence interval (CI) 1.2-1.4], T1 stage (OR 1.5, 95% CI 1.4-1.6), and head and neck primary (OR 1.4, 95% CI 1.3-1.4) all predicted RM of less than 1 cm. Factors predictive of noncompliance with SLNB recommendations included age more than 60 years (OR 1.6, 95% CI 1.5-1.8), T1 stage (OR 2.0, 95% CI 1.8-2.2), head and neck primary (OR 2.0, 95% CI 1.9-2.2), and RM less than 1 cm (OR 2.1, 95% CI 2.0-2.2). RMs and appropriate SLNB are inadequate in the majority of patients currently being treated for malignant melanoma in the USA. A combination of patient and physician education and perhaps regionalization of melanoma care is needed to improve compliance.
机译:国家综合癌症网络就切除边缘(RM)和区域分期制定了治疗皮肤恶性黑色素瘤的指南。这项研究的目的是评估美国普通人群对这些建议的遵守情况。检查了监测,流行病学和最终结果数据库以鉴定2004年至2008年的60 194例恶性黑色素瘤患者。采用多因素logistic回归分析确定了预测RM小于1 cm且不符合前哨淋巴结活检(SLNB)的因素。 。人口的中位年龄为60岁,平均布雷斯洛厚度为1.20±0.16毫米。大多数患者的RM均小于1厘米(58%),只有53%的合格患者经历了SLNB。 69%SLNB阳性的患者和78%可触及的淋巴结病的患者进行了区域淋巴结清扫术。超过80岁的多变量分析年龄[赔率(OR)1.3,95%置信区间(CI)1.2-1.4],T1分期(OR 1.5,95%CI 1.4-1.6)和头颈部原发性(OR 1.4) (95%CI 1.3-1.4)都预测RM小于1 cm。导致不遵守SLNB建议的因素包括年龄超过60岁(OR 1.6,95%CI 1.5-1.8),T1期(OR 2.0,95%CI 1.8-2.2),头颈部原发性(OR 2.0,95%CI) 1.9-2.2),且RM小于1厘米(OR 2.1,95%CI 2.0-2.2)。在美国,目前大多数接受恶性黑色素瘤治疗的患者中,RM和合适的SLNB均不足。需要结合患者和医生的教育,也许还需要将黑色素瘤的治疗区域化,以提高依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号